EUVIMEDEUVIMED entdecken
Editorial

When biology pushes back: Lessons from HBsAg-targeting therapies in hepatitis delta

Thomas Berg, Florian van Bömmel, Stephan Urban

Journal of Hepatology · 2026-09 · 85 (3) · 439-442

DOI: 10.1016/j.jhep.2026.06.040 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Hepatology, 2026-09. Verfasst von Thomas Berg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany. Electronic address: thomas.berg@medizin.uni-l…. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany. Electronic address: thomas.berg@medizin.uni-leipzig.de.
  • Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany.
  • Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg and German Center for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany.

Zitieren

APA

Berg, T., van Bömmel, F., & Urban, S. (2026). When biology pushes back: Lessons from HBsAg-targeting therapies in hepatitis delta. Journal of Hepatology, 85(3), 439-442. https://doi.org/10.1016/j.jhep.2026.06.040

Vancouver

Berg T, van Bömmel F, Urban S. When biology pushes back: Lessons from HBsAg-targeting therapies in hepatitis delta. Journal of Hepatology. 2026;85(3):439-442. doi:10.1016/j.jhep.2026.06.040

BibTeX
@article{Berg2026,
  author = {Berg, Thomas and van Bömmel, Florian and Urban, Stephan},
  title = {When biology pushes back: Lessons from HBsAg-targeting therapies in hepatitis delta},
  journal = {Journal of Hepatology},
  year = {2026},
  volume = {85},
  number = {3},
  pages = {439--442},
  doi = {10.1016/j.jhep.2026.06.040}
}
Kostenlos starten →